668435-05-0

Basic information

• Product Name: {[(2S,5R)-4-(3-amino-4-nitrophenyl)-5-methylmorpholin-2-yl]methyl}dimethylamine
• Synonyms: {[(2S,5R)-4-(3-amino-4-nitrophenyl)-5-methylmorpholin-2-yl]methyl}dimethylamine
• CAS NO: 668435-05-0
• Molecular Weight: 294.354
• Mol File: 668435-05-0.mol

Chemical Properties

• CAS DataBase Reference: {[(2S,5R)-4-(3-amino-4-nitrophenyl)-5-methylmorpholin-2-yl]methyl}dimethylamine(CAS DataBase Reference)
• NIST Chemistry Reference: {[(2S,5R)-4-(3-amino-4-nitrophenyl)-5-methylmorpholin-2-yl]methyl}dimethylamine(668435-05-0)
• EPA Substance Registry System: {[(2S,5R)-4-(3-amino-4-nitrophenyl)-5-methylmorpholin-2-yl]methyl}dimethylamine(668435-05-0)

Safety Data

• Hazardous Substances Data: 668435-05-0(Hazardous Substances Data)

Upstream product

• 668434-95-5 [((2S,5R)-5-methylmorpholin-2-yl)methyl]dimethylamine 
• 2369-11-1 5-fluoro-2-nitroaniline 
• 668434-99-9 [((2R,5R)-5-methylmorpholin-2-yl)methyl]dimethylamine 

Relevant articles and documents

Combination therapy with CHK1 inhibitors

Compounds of Structure I, and salts, tautomers, stereoisomers, and mixtures thereof may be used in methods of inhibiting checkpoint kinase 1 in subjects, in methods for inducing cell cycle progression, and in methods for increasing apoptosis in cells. Such compounds may be used to prepare pharmaceutical compositions and may be used in conjunction with DNA damaging agents.

BENZIMIDAZOLE QUINOLINONES AND USES THEREOF

Methods of inhibiting various enzymes and treating various conditions are provided that include administering to a subject a compound of Structure I or IB, a pharmaceutically acceptable salt thereof, a tautomer thereof, or a pharmaceutically acceptable salt of the tautomer. Compounds having the Structure I and IB have the following structures and have the variables described herein. Such compounds may be used to prepare medicaments for use in inhibiting various enzymes and for use in treating conditions mediated by such enzymes.